Literature DB >> 15212760

Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells.

Ling Wang1, Eirunn Knudsen, Yixin Jin, Sandra Gessani, Azzam A Maghazachi.   

Abstract

We demonstrate the expression of S1P(1,3,4,5) the receptors for sphingosine 1-phosphate (S1P), and LPA(1,2,3) the receptors for lysophosphatidic acid (LPA) in T helper 1 (Th1) and T helper 2 (Th2) cells. S1P and LPA induce the chemotaxis of Th1 and Th2 cells, an activity that is resistant to pertussis toxin (PTX) pretreatment in Th1, but is sensitive in Th2 cells. Also, I-TAC-induced Th1 and eotaxin-induced Th2 cell chemotaxis are blocked by PTX pretreatment. LPA but not S1P induces calcium flux response in Th1 and Th2 cells, which is due to the influx of extracellular calcium and is mediated by receptor activation, since EGTA and suramin (SUR) completely abrogate LPA-induced the release of calcium. No cross-desensitization is observed between thapsigargin (TG) and LPA in both cell types. PTX and SUR but not EGTA inhibit I-TAC- or eotaxin-induced [Ca(2+)](i) release in Th1 and Th2 cells. Our results indicate that lysophospholipids and chemokines stimulate different signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212760     DOI: 10.1016/j.cellsig.2004.02.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  15 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Authors:  Shannon K Oda; Pamela Strauch; Yuko Fujiwara; Amin Al-Shami; Tamas Oravecz; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

3.  Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation.

Authors:  Jason Emo; Nida Meednu; Timothy J Chapman; Fariba Rezaee; Marlene Balys; Troy Randall; Tirumalai Rangasamy; Steve N Georas
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

4.  Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.

Authors:  Gye Young Park; Yong Gyu Lee; Evgeny Berdyshev; Sharmilee Nyenhuis; Jian Du; Panfeng Fu; Irina A Gorshkova; Yongchao Li; Sangwoon Chung; Manjula Karpurapu; Jing Deng; Ravi Ranjan; Lei Xiao; H Ari Jaffe; Susan J Corbridge; Elizabeth A B Kelly; Nizar N Jarjour; Jerold Chun; Glenn D Prestwich; Eleanna Kaffe; Ioanna Ninou; Vassilis Aidinis; Andrew J Morris; Susan S Smyth; Steven J Ackerman; Viswanathan Natarajan; John W Christman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

5.  Effects of lysophospholipids on tumor microenvironment.

Authors:  Johannes Rolin; Azzam A Maghazachi
Journal:  Cancer Microenviron       Date:  2011-09-09

Review 6.  Roles of lysophosphatidic acid in cardiovascular physiology and disease.

Authors:  Susan S Smyth; Hsin-Yuan Cheng; Sumitra Miriyala; Manikandan Panchatcharam; Andrew J Morris
Journal:  Biochim Biophys Acta       Date:  2008-06-10

7.  Activatory properties of lysophosphatidic acid on human THP-1 cells.

Authors:  F D'Aquilio; M Procaccini; V Izzi; V Chiurchiu'; V Giambra; F Carotenuto; P Di Nardo; P M Baldini
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

Review 8.  Regulation of blood and vascular cell function by bioactive lysophospholipids.

Authors:  A J Morris; M Panchatcharam; H Y Cheng; L Federico; Z Fulkerson; S Selim; S Miriyala; D Escalante-Alcalde; S S Smyth
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 9.  Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.

Authors:  Steven J Ackerman; Gye Young Park; John W Christman; Sharmilee Nyenhuis; Evgeny Berdyshev; Viswanathan Natarajan
Journal:  Biomark Med       Date:  2016-01-14       Impact factor: 2.851

10.  Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.

Authors:  Jiancheng Hu; Shannon K Oda; Kristin Shotts; Erin E Donovan; Pamela Strauch; Lindsey M Pujanauski; Francisco Victorino; Amin Al-Shami; Yuko Fujiwara; Gabor Tigyi; Tamas Oravecz; Roberta Pelanda; Raul M Torres
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.